Octapharma AG - Company & Market Research Reports

Home /
Companies /
Octapharma AG

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

REFINE BY

KEYWORD

Blood Plasma Derivatives Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€3864EUR$4,000USD£3,304GBP

Global Plasma Therapeutics Market 2022-2026

 Report
April 2022
120 Pages
Global

From

€2415EUR$2,500USD£2,065GBP

Hemophilia Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4830EUR$5,000USD£4,130GBP

Bleeding Disorders Treatment Global Market Report 2024

 Report
December 2023
200 Pages
Global

From

€4830EUR$5,000USD£4,130GBP

Bleeding Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

 Report
October 2023
144 Pages
Global

From

€2414EUR$2,499USD£2,064GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Plasminogen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4733EUR$4,900USD£4,047GBP

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

 Report
August 2021
159 Pages
Global

From

€2656EUR$2,750USD£2,271GBP

€5313EUR$5,500USD£4,543GBP

Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

 Report
May 2023
134 Pages
Global

From

€2414EUR$2,499USD£2,064GBP

Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast & Opportunities, 2027

 Report
September 2022
114 Pages
Global

From

€4733EUR$4,900USD£4,047GBP

Global Bleeding Disorder Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

 Report
February 2024
208 Pages
Global

From

€3477EUR$3,600USD£2,974GBP

Global Geriatric Medicine Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

 Report
February 2024
178 Pages
Global

From

€3477EUR$3,600USD£2,974GBP

Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
June 2022
198 Pages
Global

From

€5573EUR$5,769USD£4,765GBP

US Intravenous Immunoglobulin Market Forecast to 2028 - Country Analysis By Type, Application, Distribution Channel, and End User

 Report
April 2023
145 Pages
United States

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

Critical Care Service Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

 Report
January 2024
99 Pages
Global

From

€3500EUR$3,881USD£3,098GBP

Asia-Pacific Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
181 Pages
Asia Pacific

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

Middle East and Africa Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
171 Pages
Middle East, Africa

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

South America Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
161 Pages

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

North America Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
166 Pages
North America

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

Europe Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

 Report
December 2022
186 Pages
Europe

From

€2029EUR$2,100USD£1,735GBP

€2898EUR$3,000USD£2,478GBP

Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, Distribution Channel, End User, and Geography

 Report
August 2022
210 Pages
Global

From

€3077EUR$3,185USD£2,631GBP

€4395EUR$4,550USD£3,758GBP

310 Results (Page 4 of 16)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.